| Literature DB >> 31988178 |
Nuria Trevijano-Contador1, Kaila M Pianalto2,3, Connie B Nichols2,3, Oscar Zaragoza4, J Andrew Alspaugh2,3, Liise-Anne Pirofski5,6.
Abstract
Human studies have shown associations between cryptococcal meningitis and reduced IgM memory B cell levels, and studies in IgM- and/or B cell-deficient mice have demonstrated increased Cryptococcus neoformans dissemination from lungs to brain. Since immunoglobulins are part of the immune milieu that C. neoformans confronts in a human host, and its ability to form titan cells is an important virulence mechanism, we determined the effect of human immunoglobulins on C. neoformans titan cell formation in vitro (i) Fluorescence microscopy showed normal human IgG and IgM bind C. neoformans (ii) C. neoformans grown in titan cell-inducing medium with IgM, not IgG, inhibited titan-like cell formation. (iii) Absorption of IgM with laminarin or curdlan (branched and linear 1-3-beta-d-glucans, respectively) decreased this effect. (iv) Transmission electron microscopy revealed that cells grown with IgM had small capsules and unique features not seen with cells grown with IgG. (v) Comparative transcriptional analysis of cell wall, capsule, and stress response genes showed that C. neoformans grown with IgM, not IgG or phosphate-buffered saline (PBS), had decreased expression of chitin synthetase, CHS1, CHS2, and CHS8, and genes encoding cell wall carbohydrate synthetases α-1-3-glucan (AGS1) and β-1,3-glucan (FKS1). IgM also decreased expression of RIM101 and HOG1, genes encoding central regulators of C. neoformans stress response pathways and cell morphogenesis. Our data show human IgM affects C. neoformans morphology in vitro and suggest that the hypothesis that human immunoglobulins may affect C. neoformans virulence in vivo warrants further investigation.Entities:
Keywords: Cryptococcus neoformanszzm321990; IgG; IgM; IgM memory B cells; beta glucans; capsule; cell wall; cryptococcosis; natural antibodies; titan cells
Year: 2020 PMID: 31988178 PMCID: PMC7093138 DOI: 10.1128/IAI.00046-20
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441